Indications and uses
Temporary Relief of general symptoms and inflammatory symptoms related to excess toxin buildup, such as: Fatigue Occasional muscle aches and pains Skin rashes Swelling
Temporary Relief of general symptoms and inflammatory symptoms related to excess toxin buildup, such as: Fatigue Occasional muscle aches and pains Skin rashes Swelling
Adults and children 12 years and older 20 drops in a little water 2 times per day Children between 12 years and 6 years of age 10 drops in a little water 2 times per day Children under 6 years consult a physician
ASCORBIC ACID 4X ANTIOXIDANT
CONJUNCTIVA TISSUE 6X DETOXIFICATION
DEHYDROEPIANDROSTERON 6X HORMONAL SUPPORT
DL-MALIC ACID 6X PROMOTE CELL METABOLISM
FUCUS VESICULOSUS 4X DETOXIFICATION
HISTIDINE 4X ANTI-INFLAMMATORY
HYALURONIDASE 6X ANTI-INFLAMMATORY
INTERLEUKIN 6 4C IMMUNE SUPPORT
LACTICUM ACIDUM 4X ANTIOXIDANT
LYMPHATIC VESSEL 6X IMMUNE SUPPORT
NADIDUM 6X METABOLIC SUPPORT
NATRUM OXALACETICUM 6X ANTIOXIDANT
NATRUM PYRUVICUM 6X ANTIOXIDANT
SODIUM SULFATE 6X, 8X, 12X, 30X, 200X ANTIOXIDANT
PHENYLALANINE 4X IMPROVE CONCENTRATION
PROLACTIN 6X IMPROVE CONCENTRATION
PYROGENIUM 12X ANTI-INFLAMMATORY
THUJA OCCIDENTALIS 6X, 8X, 12X, 30X, 200X DETOXIFICATION
TRICHINOYL PHOSPHATE 6X ANTIOXIDANT
TYROSINE 4X IMMUNE SUPPORT
Temporary Relief of general symptoms and inflammatory symptoms related to excess toxin buildup, such as:
If pregnant or breast-feeding ask a doctor before use
Keep out of reach of children
Adults and children 12 years and older 20 drops in a little water 2 times per day
Children between 12 years and 6 years of age 10 drops in a little water 2 times per day
Children under 6 years consult a physician
Questions?: info@gunainc.com
Tel. (484) 223-3500
Inactive ingredient: Ethyl alcohol 30%.
Take 15 minutes before meals
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | Data Matrix | 5USMAT | 5USMAT.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17089-416-18 | 2020-03-13 | C162847 | 48780-1 | 9d75b9d1-23b8-f424-e053-dadaa90a57ce | GUNA-MATRIX |
| 17089-416-18 | 2020-03-13 | C162847 | 48780-1 | 9d75b9d1-23b8-f424-e053-dadaa90a57ce | GUNA-MATRIX |
| 17089-416-18 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-23b8-f424-e053-dadaa90a57ce | GUNA-MATRIX |
| 17089-416-18 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-23b8-f424-e053-dadaa90a57ce | GUNA-MATRIX |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ASCORBIC ACID | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| DODECAHYDROXYCYCLOHEXANE DIHYDRATE | ACTIVE INGREDIENT | 5BWD2J7B4W | 1 | |
| FUCUS VESICULOSUS | ACTIVE INGREDIENT | 535G2ABX9M | 1 | |
| HISTIDINE MONOHYDROCHLORIDE | ACTIVE INGREDIENT | 1D5Q932XM6 | 1 | |
| HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) | ACTIVE INGREDIENT | 92QVL9080Y | 1 | |
| HYALURONIDASE | ACTIVE INGREDIENT | 8KOG53Z5EM | 1 | |
| LACTIC ACID, DL- | ACTIVE INGREDIENT | 3B8D35Y7S4 | 1 | |
| MALIC ACID | ACTIVE INGREDIENT | 817L1N4CKP | 1 | |
| NADIDE | ACTIVE INGREDIENT | 0U46U6E8UK | 1 | |
| PHENYLALANINE | ACTIVE INGREDIENT | 47E5O17Y3R | 1 | |
| PRASTERONE | ACTIVE INGREDIENT | 459AG36T1B | 1 | |
| PROLACTIN | ACTIVE INGREDIENT | 2S58538ZG2 | 1 | |
| RANCID BEEF | ACTIVE INGREDIENT | 29SUH5R3HU | 1 | |
| SODIUM DIETHYL OXALACETATE | ACTIVE INGREDIENT | 6CA025Y4FG | 1 | |
| SODIUM PYRUVATE | ACTIVE INGREDIENT | POD38AIF08 | 1 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 1 | |
| SUS SCROFA CONJUNCTIVA | ACTIVE INGREDIENT | W61ME6Q717 | 1 | |
| SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE | ACTIVE INGREDIENT | 308LM01C72 | 1 | |
| THUJA OCCIDENTALIS TWIG | ACTIVE INGREDIENT | 1NT28V9397 | 1 | |
| TYROSINE | ACTIVE INGREDIENT | 42HK56048U | 1 | |
| ASCORBIC ACID | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| DIETHYL OXALACETATE | ACTIVE MOIETY | 15S56468G7 | 1 | |
| DODECAHYDROXYCYCLOHEXANE | ACTIVE MOIETY | I1Z9VS3H64 | 1 | |
| FUCUS VESICULOSUS | ACTIVE MOIETY | 535G2ABX9M | 1 | |
| HISTIDINE | ACTIVE MOIETY | 4QD397987E | 1 | |
| HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) | ACTIVE MOIETY | 92QVL9080Y | 1 | |
| HYALURONIDASE | ACTIVE MOIETY | 8KOG53Z5EM | 1 | |
| LACTIC ACID, DL- | ACTIVE MOIETY | 3B8D35Y7S4 | 1 | |
| MALIC ACID | ACTIVE MOIETY | 817L1N4CKP | 1 | |
| NADIDE | ACTIVE MOIETY | 0U46U6E8UK | 1 | |
| PHENYLALANINE | ACTIVE MOIETY | 47E5O17Y3R | 1 | |
| PRASTERONE | ACTIVE MOIETY | 459AG36T1B | 1 | |
| PROLACTIN | ACTIVE MOIETY | 2S58538ZG2 | 1 | |
| PYRUVIC ACID | ACTIVE MOIETY | 8558G7RUTR | 1 | |
| RANCID BEEF | ACTIVE MOIETY | 29SUH5R3HU | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| SUS SCROFA CONJUNCTIVA | ACTIVE MOIETY | W61ME6Q717 | 1 | |
| SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE | ACTIVE MOIETY | 308LM01C72 | 1 | |
| THUJA OCCIDENTALIS TWIG | ACTIVE MOIETY | 1NT28V9397 | 1 | |
| TYROSINE | ACTIVE MOIETY | 42HK56048U | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17089-416 | 17089-416-18 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 5 | 2022-11-15 | full-release | 2026-06-01 02:18:34 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GUNA-MATRIX | ASCORBIC ACID - DODECAHYDROXYCYCLOHEXANE DIHYDRATE - FUCUS VESICULOSUS - HISTIDINE MONOHYDROCHLORIDE - HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) - HYALURONIDASE - LACTIC ACID, DL - MALIC ACID - NADIDE - PHENYLALANINE - PRASTERONE - PROLACTIN - RANCID BEEF - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SODIUM SULFATE - SUS SCROFA CONJUNCTIVA - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - THUJA OCCIDENTALIS TWIG - TYROSINE - | Guna spa | fa9ed512-97dc-44a2-b32d-86ca8c240532 | 2026-06-11 | Warnings | 17089-416-18 17089-416 17089041618 53f5a156-3403-726e-e063-6394a90a1111 fa9ed512-97dc-44a2-b32d-86ca8c240532 |
Adverse event summaries are temporarily unavailable. Other product information remains available.